investors-2019-new

Why invest in Aspen?

Aspen is a global specialty and branded pharmaceutical company, intent on improving the health of patients across the world by providing high quality and affordable medicines. Headquartered in Durban, South Africa and with a 160 year heritage, we are active at every stage of the pharmaceutical value chain. The Group is uniquely diversified by geography, product and manufacturing capability, positioning us to maximise the value creation for its diverse stakeholders.

We have 70 established business operations in 55 countries and provide medicines and products in more than 150 countries. Our key business segments are Manufacturing and Commercial Pharmaceuticals comprising Regional Brands and Sterile Focus Brands that include Anaesthetics and Thrombosis

Aspen is the largest pharmaceutical company listed on the JSE Limited (share code: APN) and is a constituent of the FTSE/JSE Responsible Investment Index.

The Group operates 23 manufacturing facilities across 15 sites and holds international manufacturing approvals from some of the most stringent global regulatory agencies. Our manufacturing capabilities are scalable to demand and cover a wide variety of product-types including injectables, oral solid dose, liquids, semi-solids, steriles, biologicals and active pharmaceutical ingredients.

QUICK FACTS

Market capitalisation


R45,8 billion*

*As at 30 June 2019

Manufacturing facilities


23

 

SITES ACROSS THE GROUP


13

 

NUMBER OF Continents


6

APPROXIMATE Employees


10 000

OUR INVESTMENT CASE

Leveraging our strengths and capabilities to deliver long-term shareholder value, while living the Aspen values.

Please click on a title below left for more information.
Responsible corporate citizen and a trusted partner

Responsible corporate citizen and a trusted partner

  • We are committed to effective and robust corporate governance making us a trusted partner. Recent high profile corporate challenges have further heightened our attention to governance and we remain committed to continuously improving our reporting, transparency and disclosure.
  • We are a signatory to the United Nations Global Compact ("UN Global Compact") Initiative.
  • A constituent of the FTSE/JSE Responsible Investment Index.
Strategically relevant manufacturing capital
Global footprint with a focus on emerging markets
Diverse, branded product portfolio
Committed management team, strongly aligned with shareholders' interests